CAM
CGEM icon

ClariVest Asset Management’s Cullinan Oncology CGEM Stock Holding History

ClariVest Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$453 Hold
26
– – ﹤0.01% 793
2024
Q2 		$453 Sell
26
-60
-70% -$1.28K ﹤0.01% 793
2024
Q1 		$1.47K Buy
86
+32
+59% +$494 ﹤0.01% 615
2023
Q4 		$550 Hold
54
– – ﹤0.01% 804
2023
Q3 		$0 Hold
54
– – ﹤0.01% 767
2023
Q2 		$1K Hold
54
– – ﹤0.01% 585
2023
Q1 		$1K Hold
54
– – ﹤0.01% 624
2022
Q4 		$1K Buy
54
+25
+86% +$304 ﹤0.01% 600
2022
Q3 		$0 Hold
29
– – ﹤0.01% 693
2022
Q2 		$0 Sell
29
-30
-51% -$340 ﹤0.01% 695
2022
Q1 		$0 Hold
59
– – ﹤0.01% 733
2021
Q4 		$0 Hold
59
– – ﹤0.01% 759
2021
Q3 		$2K Hold
59
– – ﹤0.01% 620
2021
Q2 		$2K Buy
+59
New +$1.81K ﹤0.01% 608

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return